Furassol pore. prigot. solution for places. and plank beds. approx. 100 mg pack. laminate. 1y No. 15

Product form, composition and packaging Powder for preparation of solution for local and external use, orange-brown color, large.

1 pack.

(1 g)

furazidine potassium

100 mg

sodium chloride - 900 mg.

1 g - laminate sachets (15) - cardboard packs.

pharmachologic effect

Antimicrobial drug derived from nitrofuran.

Effective against gram-positive cocci (Staphylococcus spp., Streptococcus spp.), Gram-negative bacilli (Escherichia coli, Salmonella spp., Shigella spp., Klebsiella spp.).

Resistant to Acinetobacter spp., Most of Proteus spp., Serratia spp.

The mechanism of action is associated with inhibition of the synthesis of nucleic acids.

Depending on the concentration, it has a bactericidal or bacteriostatic effect.

Against most bacteria, the bacteriostatic concentration is 10-20 Ојg / ml.

The bactericidal concentration is approximately 2 times higher.

Under the influence of nitrofurans in microorganisms, the activity of the respiratory chain and the tricarboxylic acid cycle (Krebs cycle) is suppressed, as well as the suppression of other biochemical processes, which leads to the destruction of their membrane or cytoplasmic membrane.

Nitrofurans increase the complement titer and the ability of leukocytes to phagocytose microorganisms. Pharmacokinetics Data on the pharmacokinetics of the drug Furasolne are provided.

Indications for use

With complex treatment:

- infectious and inflammatory diseases of the oral cavity, oropharynx

- small wounds with a threat of infection (including abrasions, scratches, small cuts and scratches, cracks, mild burns). Contraindications to use - allergic dermatitis

- pregnancy

- lactation period (breastfeeding)

- children under 4 years old

- hypersensitivity to furazidine or nitrofuran drugs.

Dosage regimen

The drug is intended for local and external use.

The solution is prepared immediately before use.

The contents of the sachet are dissolved in 200 ml of hot boiled water.

Topically: a warm solution is used to rinse the mouth and oropharynx 2-3 times / day.

Outwardly: a warm solution is used to wash the wounds 1-2 times / day.

Duration of treatment is 3-5 days. Overdose The drug is low-toxic.

Overdose cases are not described. Side effect Classification of adverse reactions by frequency of development: very often (> = 10%), often (> = 1%, but < 10%), infrequently (> = 0.1%, but < 1%), rarely ( > = 0.01%, but < 0.1%), very rare (< 0.01%), frequency unknown (cannot be determined from available data).

Allergic reactions: frequency unknown - urticaria, itching, rash, allergic dermatitis.

If unusual reactions occur, the patient should consult a doctor about the appropriateness of further use of the drug. Drug Interaction In combination with antibiotics, it shows synergy.

In the case of alcohol consumption during treatment with the drug, the likelihood of developing allergic skin reactions increases.

Application during pregnancy and lactation

The use of the drug during pregnancy and lactation is contraindicated.

special instructions

With the development of adverse reactions, the drug should be canceled and symptomatic therapy should be prescribed.

The solution is prepared immediately before use.

Do not store the prepared solution.

Influence on the ability to drive vehicles and mechanisms

The use of the drug does not affect the ability to drive vehicles and mechanisms.

Name ENG

FURASOL

Clinical and pharmacological group

Antibacterial and antiprotozoal drug for external and local use.

Nitrofuran derivative

ATX code

Other antimicrobial drugs

Dosage

100mg x 1g

INN / Active ingredient

furazidine potassium

Storage conditions and periods

In a dark place at a temperature not exceeding 25 degrees.

Expiration date: 5 years

Specifications

Scope of the drug

General

Release form

Powder

Manufacturer country

Latvia

Package quantity, pcs

15

Vacation conditions

On prescription

Brand name

Olainfarm

The amount of the dosage form in the primary package

1 g

Primary packaging type

Laminated bag

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antimicrobial agent - nitrofuran

Anatomical and therapeutic characteristics

D06BX Other antimicrobials

Dosage (volume) of the substance in the preparation

furazidine potassium 100 mg

Expiration date in days

1825

The target audience

Adult

Package weight, g

45

Category

:

Antibiotics

,

Antiseptics and disinfectants

,

Disinfectants

Dosage form

:

Powder for preparation of a solution for local and external use